Long-term effects of cancer therapy in children - functional effects, late mortality and long-term follow-up

Paediatrics and Child Health (United Kingdom)

Volumn 22, Issue 6, 2012, Pages 248-252

  Skinner, Roderick ^a  

^a Infectious Diseases Allergy   (United Kingdom)

Author keywords

Cancer; Chemotherapy; Child; Late adverse effects; Leukaemia; Long term follow up; Radiotherapy; Survivorship; Transition

Indexed keywords

GROWTH HORMONE;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; FOLLOW UP; FUNCTIONAL STATUS; GROWTH HORMONE DEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR SURGERY; QUALITY OF LIFE; REVIEW; SURVIVOR; TREATMENT DURATION;

EID: 84862315077     PISSN: 17517222     EISSN: 1878206X     Source Type: Journal    
DOI: 10.1016/j.paed.2012.02.008     Document Type: Review

References (13)

1. Armstrong G.T., Lui Q., Yasui Y., et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 2009, 101:946-958.
2. Aslett H., Levitt G., Richardson A., Gibson F. A review of long-term follow-up for survivors of childhood cancer. Eur J Cancer 2007, 43:1781-1790.
3. Bresters D., van Gils I.C.M., Kollen W.J.W., et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2010, 45:79-85.
4. Children's Oncology Group (COG) Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (version 3.0) 2008, http://www.survivorshipguidelines.org/.
5. Gurney J.G., Ness K.K., Sibley S.D., et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006, 107:1303-1312.
6. Kirchhoff A.C., Krull K.R., Ness K.K., et al. Physical, mental and neurocognitive status and employment outcomes in the Childhood Cancer Survivor Study cohort. Cancer Epidemiol Biomarkers Prev 2011, 20:1838-1849.
7. Reulen R.C., Frobisher C., Winter D.L., on behalf of the British Childhood Cancer Survivor Study, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011, 305:2311-2319.
8. Reulen R.C., Winter D.L., Frobisher C., on behalf of the British Childhood Cancer Survivor Study, et al. Population-based risks of specific causes of death up to 55 years after childhood cancer: the British Childhood Cancer Survivor Study. JAMA 2010, 304:172-179.
9. Reulen R.C., Winter D.L., Lancashire E.R., et al. Health-status of adult survivors of childhood cancer: a large-scale population-based study from the British Childhood Cancer Survivor Study. Int J Cancer 2007, 121:633-640.
10. Skinner R., Wallace W.H.B., Levitt G.A., on behalf of the UK Children's Cancer Study Group (UKCCSG) Late Effects Group (LEG) Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol 2006, 7:489-498.
11. United Kingdom Children's Cancer Study Group (UKCCSG) Late effects group therapy based long term follow up practice statement 2005, http://www.cclg.org.uk/treatmentandresearch/content.php%3F3id%3D29%262id%3D19, 2nd Edn.
12. Late effects of childhood cancer 2004, Arnold, London. W.H.B. Wallace, D.M. Green (Eds.).
13. Endocrinopathy after childhood cancer treatment 2009, Karger, Basel. W.H.B. Wallace, C.J.H. Kelnar (Eds.).